Last reviewed · How we verify
Prostacyclin Receptor Agonist — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Prostacyclin Receptor Agonist (Prostacyclin Receptor Agonist) — Actelion.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prostacyclin Receptor Agonist TARGET | Prostacyclin Receptor Agonist | Actelion | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prostacyclin Receptor Agonist CI watch — RSS
- Prostacyclin Receptor Agonist CI watch — Atom
- Prostacyclin Receptor Agonist CI watch — JSON
- Prostacyclin Receptor Agonist alone — RSS
Cite this brief
Drug Landscape (2026). Prostacyclin Receptor Agonist — Competitive Intelligence Brief. https://druglandscape.com/ci/prostacyclin-receptor-agonist. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab